Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History.
Sanjay SethiBrendan ClarkLindsay G S BengtsonErin K BuysmanSwetha PalliAndrew SargentAsif ShaikhGary T FergusonPublished in: International journal of chronic obstructive pulmonary disease (2023)
These real-world results support ATS and GOLD recommendations for treating low-exacerbation risk COPD patients with dual bronchodilators and TT for more severe, higher-exacerbation risk COPD patients.